Medrogestone

Medrogestone is a new orally active Progestin. Medrogestone shows a marked local progestational effect. Medrogestone maintains pregnancy in ovariectomized rats. Medrogestone inhibits ovulation. Medrogestone prevents pregnancy. Medrogestone produces a significant reduction in the severity of benign prostatic hypertrophy[1][2].

Product Specifications

CAS Number

[977-79-7]

UNSPSC

12352211

Hazard Statement

H315-H319-H320

Target

Progesterone Receptor

Related Pathways

Vitamin D Related/Nuclear Receptor

Field of Research

Endocrinology

Smiles

CC([C@@]1(C)CC[C@@]2([H])[C@]3([H])C=C(C)C4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O

Molecular Formula

C23H32O2

Molecular Weight

340.50

Precautions

P264-P280-P302+P352-P305+P351+P338-P362

References & Citations

[1]Revesz C, et al. Biological activity of medrogestone: a new orally active progestin. J Reprod Fertil. 1966 Dec;12 (3) :473-87. |[2]Rangno RE, et al. Treatment of benign prostatic hypertrophy with medrogestone. Clin Pharmacol Ther. 1971 Jul-Aug;12 (4) :658-65.